Our results, derived from the analysis of the largest available cohort with VHL germline mutations (to our knowledge), reveal previously unknown mutation- and organ-specific differences in tumor penetrance, number of organs affected, number of surgeries and outcome. This evidence concerns the gene VHL and neoplasm.